News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Baxter International, Inc. (BAX) Dodges Foreign Bribery Beef



2/24/2014 8:14:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Federal regulators close an investigation into Baxter's Chinese operations without taking any action against the healthcare giant. Baxter (NYSE:BAX) closed the books on a federal bribery investigation after regulators dropped the probe without finding wrongdoing, the company announced. The investigation was part of an industry-wide foreign bribery inquiry in which regulators from the SEC and the DOJ asked medical device makers to voluntarily review their own overseas operations.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES